Cargando…

Inter‐alpha‐trypsin inhibitor heavy chain 4: A serologic marker relating to disease risk, activity, and treatment outcomes of rheumatoid arthritis

OBJECTIVE: Inter‐alpha‐trypsin inhibitor heavy chain 4 (ITIH4) regulates immunity and inflammation, but its clinical role in rheumatoid arthritis (RA) patients remains unclear. Hence, this study was conducted to explore the association of circulating ITIH4 with disease risk, clinical features, infla...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Kejian, He, Sanshan, Su, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906037/ https://www.ncbi.nlm.nih.gov/pubmed/35064701 http://dx.doi.org/10.1002/jcla.24231

Ejemplares similares

Identification of novel biomarker as citrullinated inter-alpha-trypsin inhibitor heavy chain 4, specifically increased in sera with experimental and rheumatoid arthritis
por: Kawaguchi, Hoshimi, et al.
Publicado: (2018)

Site-Specific Glycan Microheterogeneity of Inter-Alpha-Trypsin Inhibitor Heavy Chain H4
por: Chandler, Kevin Brown, et al.
Publicado: (2014)

A Prospective Cohort Study of Inter-Alpha-Trypsin Inhibitor Heavy Chain 4 as a Serologic Marker in Relation to Severity and Functional Outcome of Acute Intracerebral Hemorrhage
por: Shentu, Hua-Song, et al.
Publicado: (2023)

Inter-Alpha-Trypsin Inhibitor Heavy Chain 4 Plays an Important Role in the Development and Reproduction of Nilaparvata lugens
por: Ji, Jin-Liang, et al.
Publicado: (2022)

Relationship between inter-α-trypsin inhibitor heavy chain 4 and ovarian cancer
por: Huang, Min, et al.
Publicado: (2019)

Opposing roles of inter-α-trypsin inhibitor heavy chain 4 in recurrent pregnancy loss
por: Li, Lan, et al.
Publicado: (2018)

SNP analysis of the inter-alpha-trypsin inhibitor family heavy chain-related protein (IHRP) gene by a fluorescence-adapted SSCP method
por: Tozaki, Teruaki, et al.
Publicado: (2002)

Serum Inter-Alpha-Trypsin Inhibitor Heavy Chain 4 (ITIH4) in Children with Chronic Hepatitis C: Relation to Liver Fibrosis and Viremia
por: Sira, Mostafa M., et al.
Publicado: (2014)

Plasma Inter-Alpha-Trypsin Inhibitor Heavy Chains H3 and H4 Serve as Novel Diagnostic Biomarkers in Human Colorectal Cancer
por: Jiang, Xiao, et al.
Publicado: (2019)

Inter-alpha-trypsin inhibitor heavy chain 4: a novel biomarker for environmental exposure to particulate air pollution in patients with chronic obstructive pulmonary disease
por: Lee, Kang-Yun, et al.
Publicado: (2015)

Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: A systematic expression analysis
por: Hamm, Alexander, et al.
Publicado: (2008)

Longitudinal change of serum inter‐alpha‐trypsin inhibitor heavy chain H4, and its correlation with inflammation, multiorgan injury, and death risk in sepsis
por: Zhao, Xiangwang, et al.
Publicado: (2023)

Patients with ovarian carcinoma excrete different altered levels of urine CD59, kininogen-1 and fragments of inter-alpha-trypsin inhibitor heavy chain H4 and albumin
por: Abdullah-Soheimi, Siti S, et al.
Publicado: (2010)

Time course of inflammatory cytokines in acute ischemic stroke patients and their relation to inter-alfa trypsin inhibitor heavy chain 4 and outcome
por: Nayak, Amit R., et al.
Publicado: (2012)

Network proteomic analysis identifies inter-alpha-trypsin inhibitor heavy chain 4 during early human Achilles tendon healing as a prognostic biomarker of good long-term outcomes
por: Wu, Xinjie, et al.
Publicado: (2023)

Glutathione and Inter-α-trypsin inhibitor heavy chain 3 (Itih3) mRNA levels in nicotine-treated Cd44 knockout mice
por: Wickramasekara, Rochelle N., et al.
Publicado: (2018)

Urine inter‐alpha‐trypsin inhibitor family‐related proteins may serve as biomarkers for disease activity of lupus
por: Jiang, Jun, et al.
Publicado: (2022)

Serological markers associated with disease activity in patients with rheumatoid arthritis treated with rituximab
por: Conigliaro, Paola, et al.
Publicado: (2016)

Relative Abundance of Alpha-Amylase/Trypsin Inhibitors in Selected Sorghum Cultivars
por: Sagu, Sorel Tchewonpi, et al.
Publicado: (2020)

ISOLATION FROM BEEF PANCREAS OF CRYSTALLINE TRYPSINOGEN, TRYPSIN, A TRYPSIN INHIBITOR, AND AN INHIBITOR-TRYPSIN COMPOUND
por: Kunitz, M., et al.
Publicado: (1936)

Circulating DNA in rheumatoid arthritis: pathological changes and association with clinically used serological markers
por: Rykova, Elena, et al.
Publicado: (2017)

Gamma heavy chain disease associated with rheumatoid arthritis: a case report
por: Danic, Gwenvaël, et al.
Publicado: (2021)

Contribution of bacterial pathogens to evoking serological disease markers and aggravating disease activity in rheumatoid arthritis
por: Terato, Kuniaki, et al.
Publicado: (2018)

Identification of a Novel Serological Marker in Seronegative Rheumatoid Arthritis Using the Peptide Library Approach
por: Bason, Caterina, et al.
Publicado: (2021)

Gamma heavy chain disease in a patient with rheumatoid arthritis – a laboratory evaluation
por: Johannis, Wibke, et al.
Publicado: (2012)

Clinical and serological characteristics of Ecuadorian patients with rheumatoid arthritis
por: Ríos, Carlos, et al.
Publicado: (2017)

TATI (tumour-associated trypsin inhibitor) as a marker of ovarian cancer.
por: Medl, M., et al.
Publicado: (1995)

Enhanced expression of a 35 kDa fragment of inter-alpha-trypsin inhibitor H4 in sera of healthy pregnant women and patients with hydatidiform mole
por: Mohamed, Emida, et al.
Publicado: (2013)

Digestibility of wheat alpha-amylase/trypsin inhibitors using a caricain digestive supplement
por: Juhász, Angéla, et al.
Publicado: (2022)

The Action of Crystalline Trypsin and Soybean Trypsin Inhibitor on the Clotting of Blood by Staphylocoagulase
por: Tager, Morris
Publicado: (1952)

ISOLATION OF A CRYSTALLINE PROTEIN COMPOUND OF TRYPSIN AND OF SOYBEAN TRYPSIN-INHIBITOR
por: Kunitz, M.
Publicado: (1947)

CRYSTALLINE SOYBEAN TRYPSIN INHIBITOR
por: Kunitz, M.
Publicado: (1946)

Anti-CCP2 Antibodies: An Overview and Perspective of the Diagnostic Abilities of this Serological Marker for Early Rheumatoid Arthritis
por: van Venrooij, Walther J., et al.
Publicado: (2007)

Markers in rheumatoid arthritis
por: Breedveld, FC
Publicado: (2004)

Effect of Ionic Strength on the Kinetics of Trypsin and Alpha Chymotrypsin
por: Castañeda-Agulló, M., et al.
Publicado: (1961)

Cardiovascular Risk Associated With TNF Alpha Inhibitor Use in Patients With Rheumatoid Arthritis
por: Hussain, Aaiz, et al.
Publicado: (2021)

Marker assisted accelerated introgression of null allele of kunitz trypsin inhibitor in soybean
por: Kumar, Vineet, et al.
Publicado: (2015)

Serological identification of fast progressors of structural damage with rheumatoid arthritis
por: Siebuhr, Anne Sofie, et al.
Publicado: (2013)

Research progress on serological indices and their clinical application in rheumatoid arthritis
por: Meng, Shuting, et al.
Publicado: (2022)

Interactions between Soybean Trypsin Inhibitor and Chitosan in an Aqueous Solution
por: Zhang, Yihao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u37bf4bka2208ovh1vjj7b9bhu